These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 19470182)

  • 1. Fractionated irradiation induced radio-resistant esophageal cancer EC109 cells seem to be more sensitive to chemotherapeutic drugs.
    Xie L; Song X; Yu J; Wei L; Song B; Wang X; Lv L
    J Exp Clin Cancer Res; 2009 May; 28(1):68. PubMed ID: 19470182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment and characterization of a paclitaxel‑resistant human esophageal carcinoma cell line.
    Wang C; Guo LB; Ma JY; Li YM; Liu HM
    Int J Oncol; 2013 Nov; 43(5):1607-17. PubMed ID: 24002547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells.
    Wang C; Guo L; Wang S; Wang J; Li Y; Dou Y; Wang R; Shi H; Ke Y; Liu H
    Int J Mol Med; 2017 Mar; 39(3):645-653. PubMed ID: 28204832
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal combination chemotherapy and chemoradiotherapy with etoposide for advanced cervical squamous cancer cells in vitro.
    Tanaka T; Bai T; Yukawa K; Umesaki N
    Oncol Rep; 2006 Apr; 15(4):939-47. PubMed ID: 16525683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Establishment and biological analysis of the EC109/CDDP multidrug-resistant esophageal squamous cell carcinoma cell line.
    Wen J; Zheng B; Hu Y; Zhang X; Yang H; Luo KJ; Zhang X; Li YF; Fu JH
    Oncol Rep; 2009 Jul; 22(1):65-71. PubMed ID: 19513506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic growth suppression induced in esophageal squamous cell carcinoma cells by combined treatment with docetaxel and heavy carbon-ion beam irradiation.
    Kitabayashi H; Shimada H; Yamada S; Yasuda S; Kamata T; Ando K; Tsujii H; Ochiai T
    Oncol Rep; 2006 Apr; 15(4):913-8. PubMed ID: 16525679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigallocatechin-3-gallate promotes apoptosis and reversal of multidrug resistance in esophageal cancer cells.
    Liu L; Ju Y; Wang J; Zhou R
    Pathol Res Pract; 2017 Oct; 213(10):1242-1250. PubMed ID: 28964574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemosensitivity of radioresistant cells in the multicellular spheroids of A549 lung adenocarcinoma.
    Shi D; Shi G; Huang G; Zhang J; Lartigau E
    J Exp Clin Cancer Res; 2009 Jun; 28(1):72. PubMed ID: 19490637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Krüppel-Like Factor 4 Enhances Sensitivity of Cisplatin to Esophageal Squamous Cell Carcinoma (ESCC) Cells.
    Chen C; Ma Z; Zhang H; Liu X; Yu Z
    Med Sci Monit; 2017 Jul; 23():3353-3359. PubMed ID: 28694421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of altered WIG-1 expression on DDP sensitivity in a DDP-resistant esophageal squamous cancer cell line.
    Qiu Y; Zou YB; Li K; Jiang YG; Yang K; Zhao YP; Guo W
    Curr Cancer Drug Targets; 2012 Oct; 12(8):950-61. PubMed ID: 22794122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Anti-tumor effects of chemotherapeutic drugs on human gastric cancer cells in vitro and the relationship with expression of hTERT mRNA].
    Geng M; Yin YC; Cao YC; Fu ZJ; Wang XY; Tai YH
    Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):838-41. PubMed ID: 18396642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma.
    Zhang H; Li M; Han Y; Hong L; Gong T; Sun L; Zheng X
    Dig Dis Sci; 2010 Sep; 55(9):2545-51. PubMed ID: 19960259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting the Bcl-2 family and P-glycoprotein reverses paclitaxel resistance in human esophageal carcinoma cell line.
    Shi X; Dou Y; Zhou K; Huo J; Yang T; Qin T; Liu W; Wang S; Yang D; Chang L; Wang C
    Biomed Pharmacother; 2017 Jun; 90():897-905. PubMed ID: 28441715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insights into anticancer activity and mechanism of action of a ruthenium(II) complex in human esophageal squamous carcinoma EC109 cells.
    Guo L; Lv G; Qiu L; Yang H; Zhang L; Yu H; Zou M; Lin J
    Eur J Pharmacol; 2016 Sep; 786():60-71. PubMed ID: 27262377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of autophagy counteracts the anticancer effect of cisplatin in human esophageal cancer cells with acquired drug resistance.
    Yu L; Gu C; Zhong D; Shi L; Kong Y; Zhou Z; Liu S
    Cancer Lett; 2014 Dec; 355(1):34-45. PubMed ID: 25236911
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of specific apoptotic pathways in the restoration of paclitaxel-induced apoptosis by valspodar in doxorubicin-resistant MCF-7 breast cancer cells.
    Chadderton A; Villeneuve DJ; Gluck S; Kirwan-Rhude AF; Gannon BR; Blais DE; Parissenti AM
    Breast Cancer Res Treat; 2000 Feb; 59(3):231-44. PubMed ID: 10832593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bortezomib sensitizes esophageal squamous cancer cells to radiotherapy by suppressing the expression of HIF-1α and apoptosis proteins.
    Wang D; Qin Q; Jiang QJ; Wang DF
    J Xray Sci Technol; 2016 Apr; 24(4):639-46. PubMed ID: 27080362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth inhibitory effects of trastuzumab and chemotherapeutic drugs in gastric cancer cell lines.
    Gong SJ; Jin CJ; Rha SY; Chung HC
    Cancer Lett; 2004 Oct; 214(2):215-24. PubMed ID: 15363548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of combinations of HER-2/neu antibody and chemotherapeutic agents used for treatment of human breast cancers.
    Pegram M; Hsu S; Lewis G; Pietras R; Beryt M; Sliwkowski M; Coombs D; Baly D; Kabbinavar F; Slamon D
    Oncogene; 1999 Apr; 18(13):2241-51. PubMed ID: 10327070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cisplatin induces drug resistance in human esophageal squamous carcinoma cell line EC109 by decreasing CTR1 protein expression].
    Yu L; Chen MH; Gu CP; Li YL; Wen J; Fu JH; Cho CH; Liu SW
    Nan Fang Yi Ke Da Xue Xue Bao; 2011 May; 31(5):801-4. PubMed ID: 21602128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.